SCHEMBL8663746

SCHEMBL8663746

C=CCS[C]1CCc2ccccc2N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.43
▸ MAPK13 O15264 1/20 0.43
▸ MAPK12 P53778 1/20 0.43
▸ MAPK11 Q15759 1/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ MAPT P10636 4/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ ALDH1A1 P00352 5/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ AHR P35869 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL407439 0.70 NPC1 (0.70) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL1893352 0.68 ALDH1A1 (0.46) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL11498921 0.68 NOS3 (0.43) NPC1MAPTMEN1KMT2AKDM4E
SCHEMBL134599 0.65 NPC1 (0.57) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL6469101 0.63 NPC1 (0.72) NPC1MAPK13MAPK12MAPK11MAPK14
Oxindole SCHEMBL28517700 0.62 AHR (0.70) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL4861947 0.62 MAPT (0.72) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL10351891 0.62 MEN1 (0.48) MEN1KMT2AALDH1A1L3MBTL1HPGD
SCHEMBL8549657 0.61 NPC1 (0.57) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL4227502 0.61 NPC1 (1.00) NPC1MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825986-A1 QUINOLYL-ETHYNYL DERIVATIVES HAVING RETINOID-LIKE ACTIVITY Allergan (US) 1998-03-04 — — EP disclosed
US-5616712-A SKIN DISORDERS; ANTICARCINOGENIC AND -INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; ALLERGAN (US) 1997-04-01 — — US disclosed
US-5616712-A SKIN DISORDERS; ANTICARCINOGENIC AND -INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; ALLERGAN (US) 1997-04-01 — — US disclosed
WO-1996036609-A1 QUINOLYL-ETHYNYL DERIVATIVES HAVING RETINOID-LIKE ACTIVITY ALLERGAN (US) 1996-11-21 — — WO disclosed
Send feedback